Tartrazine


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
10013 HDAC6 Increases expression PMID:40077783
10014 HDAC5 Increases expression PMID:40077783
1017 CDK2 Increases expression PMID:31032366
1027 CDKN1B Increases expression PMID:31032366
1277 COL1A1 Increases expression PMID:30847814
1786 DNMT1 Increases expression PMID:37447272; PMID:40077783
1788 DNMT3A Increases expression PMID:37447272; PMID:40077783
1789 DNMT3B Increases expression PMID:37447272; PMID:40077783
2099 ESR1 Increases activity PMID:22562034
213 ALB Increases expression PMID:22317828
2335 FN1 Increases expression PMID:30847814
249 ALPL Increases activity PMID:30657462
249 ALPL Increases expression PMID:28243541; PMID:29854586
2805 GOT1 Increases expression PMID:28243541; PMID:30847814
2806 GOT2 Increases activity PMID:30657462
2806 GOT2 Increases expression PMID:29854586
2875 GPT Increases activity PMID:22317828; PMID:28239801; PMID:29981020; PMID:30657462
2875 GPT Increases expression PMID:28243541; PMID:29854586; PMID:30847814
2876 GPX1 Decreases activity PMID:22417523; PMID:33316931
2876 GPX1 Decreases expression PMID:33316931
2936 GSR Decreases activity PMID:29427609
2936 GSR Decreases expression PMID:29854586
3066 HDAC2 Increases expression PMID:37447272
3553 IL1B Increases expression PMID:30096597; PMID:39619970; PMID:39866447
3569 IL6 Increases expression PMID:30096597; PMID:39619970; PMID:39866447
3586 IL10 Increases expression PMID:30096597
4288 MKI67 Increases expression PMID:31032366
4846 NOS3 Increases expression PMID:30096597
55869 HDAC8 Increases expression PMID:37447272
5599 MAPK8 Increases expression PMID:28229641
598 BCL2L1 Increases expression PMID:31032366
6647 SOD1 Decreases activity PMID:22417523
6647 SOD1 Decreases expression PMID:29854586; PMID:30847814; PMID:32870427; PMID:30847814
7031 TFF1 Increases expression PMID:22562034
7040 TGFB1 Increases expression PMID:30847814
7124 TNF Decreases expression PMID:39619970; PMID:39866447
7157 TP53 Affects expression PMID:31032366; PMID:33316931
7166 TPH1 Increases expression PMID:36539404
7226 TRPM2 Decreases expression PMID:39619970; PMID:39866447
7422 VEGFA Increases expression PMID:30096597
836 CASP3 Increases expression PMID:30847814; PMID:32870427; PMID:38408527; PMID:30847814; PMID:33316931
842 CASP9 Increases expression PMID:33316931
847 CAT Decreases activity PMID:20678534; PMID:22417523; PMID:26190785; PMID:28239801; PMID:29217164; PMID:29427609; PMID:33316931
847 CAT Decreases expression PMID:29854586; PMID:30847814; PMID:32870427; PMID:30847814; PMID:33316931
8841 HDAC3 Increases expression PMID:37447272

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.